dr. Luk Corluy

• Werkt in het AZ Herentals sinds 2015
• Contact via de raadpleging inwendige ziekten: t 014 24 64 80

Publicaties

• Lemmens L, van Beek N, Corluy L, Verfaillie S “Chronic Mycobacterium kansasii tenosynovitis in an immunocompromised host : case report.” Acta Orthop Belg. 2020
• Bertrand D, Joly J, Neerinckx B, Durez P, Lenaerts J, Joos R, Thevissen K, Zwaenepoel T, Vanhoof J, Di Romana S, Taelman V, Van Essche E, Corluy L, Ribbens C, Vanden Berghe M, Devinck M, Ajeganova S, Durnez A, Boutsen Y, Margaux J, Peene I, Van Offel J, Doumen M, Pazmino S, De Meyst E, Kulyk M, Creten N, Westhovens R, Verschueren P; CareRA2020 Study group. Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trial. RMD Open. 2024 Aug 7;10(3):e004535. doi: 10.1136/rmdopen-2024- 004535. PMID: 39117445; PMCID: PMC11409310 
• Driesen A, Vulsteke JB, Corluy L, Severi S, De Crem N, Dubbeldam A, Wuyts W, De Langhe E. Interleukin 6 inhibition in refractory antisynthetase syndrome: case-based literature review. Acta Clin Belg. 2024 Oct;79(5):368- doi: 10.1080/17843286.2024.2423508. Epub 2024 Nov 10. PMID: 40053413